Campus Activewear Ltd
NSE:CAMPUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Campus Activewear Ltd
NSE:CAMPUS
|
IN |
|
J
|
Johnson Pharmacare Ltd
BSE:532154
|
IN |
|
Cranex Ltd
BSE:522001
|
IN |
|
Pitney Bowes Inc
NYSE:PBI
|
US |
Income Statement
Earnings Waterfall
Campus Activewear Ltd
Income Statement
Campus Activewear Ltd
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
174
|
0
|
0
|
0
|
273
|
0
|
0
|
0
|
223
|
0
|
0
|
0
|
168
|
0
|
0
|
0
|
|
| Revenue |
11 942
N/A
|
15 319
+28%
|
18 651
+22%
|
14 888
-20%
|
14 843
0%
|
15 003
+1%
|
14 258
-5%
|
14 322
+0%
|
14 483
+1%
|
14 337
-1%
|
15 083
+5%
|
15 511
+3%
|
15 930
+3%
|
15 971
+0%
|
16 504
+3%
|
17 242
+4%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(6 205)
|
(7 854)
|
(9 592)
|
(7 695)
|
(7 741)
|
(7 468)
|
(6 912)
|
(6 821)
|
(7 170)
|
(6 900)
|
(7 307)
|
(7 538)
|
(7 906)
|
(7 636)
|
(7 852)
|
(8 110)
|
|
| Gross Profit |
5 736
N/A
|
7 465
+30%
|
9 059
+21%
|
7 194
-21%
|
7 101
-1%
|
7 535
+6%
|
7 346
-3%
|
7 501
+2%
|
7 313
-3%
|
7 437
+2%
|
7 776
+5%
|
7 973
+3%
|
8 024
+1%
|
8 335
+4%
|
8 652
+4%
|
9 132
+6%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(3 830)
|
(5 100)
|
(6 430)
|
(5 101)
|
(5 276)
|
(5 690)
|
(5 701)
|
(6 201)
|
(5 921)
|
(6 186)
|
(6 383)
|
(6 327)
|
(6 340)
|
(6 718)
|
(6 962)
|
(7 195)
|
|
| Selling, General & Administrative |
(3 193)
|
(1 707)
|
(1 926)
|
(952)
|
(4 395)
|
(823)
|
(843)
|
(882)
|
(5 037)
|
(1 064)
|
(1 117)
|
(1 156)
|
(5 416)
|
(1 224)
|
(1 274)
|
(1 336)
|
|
| Depreciation & Amortization |
(530)
|
(678)
|
(847)
|
(666)
|
(710)
|
(736)
|
(747)
|
(735)
|
(721)
|
(713)
|
(708)
|
(713)
|
(755)
|
(794)
|
(837)
|
(872)
|
|
| Other Operating Expenses |
(107)
|
(2 716)
|
(3 657)
|
(3 483)
|
(171)
|
(4 131)
|
(4 111)
|
(4 584)
|
(163)
|
(4 409)
|
(4 559)
|
(4 457)
|
(169)
|
(4 700)
|
(4 851)
|
(4 987)
|
|
| Operating Income |
1 906
N/A
|
2 364
+24%
|
2 629
+11%
|
2 093
-20%
|
1 825
-13%
|
1 845
+1%
|
1 645
-11%
|
1 300
-21%
|
1 393
+7%
|
1 251
-10%
|
1 393
+11%
|
1 646
+18%
|
1 684
+2%
|
1 617
-4%
|
1 691
+5%
|
1 937
+15%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(171)
|
(232)
|
(308)
|
(272)
|
(266)
|
(300)
|
(289)
|
(264)
|
(209)
|
(199)
|
(179)
|
(165)
|
(81)
|
(200)
|
(218)
|
(248)
|
|
| Non-Reccuring Items |
(7)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
(9)
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(0)
|
7
|
18
|
(1)
|
24
|
21
|
26
|
23
|
66
|
96
|
119
|
40
|
186
|
203
|
221
|
|
| Pre-Tax Income |
1 717
N/A
|
2 133
+24%
|
2 328
+9%
|
1 839
-21%
|
1 566
-15%
|
1 569
+0%
|
1 377
-12%
|
1 062
-23%
|
1 200
+13%
|
1 118
-7%
|
1 310
+17%
|
1 601
+22%
|
1 639
+2%
|
1 602
-2%
|
1 676
+5%
|
1 910
+14%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(632)
|
(742)
|
(792)
|
(667)
|
(395)
|
(396)
|
(345)
|
(264)
|
(306)
|
(283)
|
(336)
|
(412)
|
(428)
|
(422)
|
(438)
|
(500)
|
|
| Income from Continuing Operations |
1 085
|
1 391
|
1 536
|
1 171
|
1 171
|
1 173
|
1 032
|
798
|
894
|
835
|
973
|
1 189
|
1 212
|
1 180
|
1 238
|
1 410
|
|
| Net Income (Common) |
1 085
N/A
|
1 399
+29%
|
1 544
+10%
|
1 171
-24%
|
1 171
0%
|
1 173
+0%
|
1 031
-12%
|
796
-23%
|
894
+12%
|
833
-7%
|
973
+17%
|
1 189
+22%
|
1 212
+2%
|
1 180
-3%
|
1 238
+5%
|
1 410
+14%
|
|
| EPS (Diluted) |
3.57
N/A
|
4.6
+29%
|
5.08
+10%
|
3.85
-24%
|
3.84
0%
|
3.84
N/A
|
3.22
-16%
|
2.6
-19%
|
2.93
+13%
|
2.72
-7%
|
3.19
+17%
|
3.89
+22%
|
3.97
+2%
|
3.82
-4%
|
4.07
+7%
|
4.6
+13%
|
|